Bay Colony Advisory Group, Inc D Bio N Tech Se Transaction History

Bay Colony Advisory Group, Inc D

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$123.25 - $186.24 $150,118 - $226,840	1,218 New	1,218 $201,000
Q1 2022 Apr 28, 2022	SELL	$126.25 - $231.85 $148,470 - $272,655	-1,176 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$216.64 - $362.52 $49,827 - $83,379	230 Added 24.31%	1,176 $303,000
Q2 2021 Jul 22, 2021	BUY	$113.32 - $241.49 $107,200 - $228,449	946 New	946 $212,000

357

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.